Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

FHLC vs. QAAGZX: which is better?

Bottom line

FHLC vs QAAGZX: the short answer

FHLC (Fidelity MSCI Health Care Index ETF) and QAAGZX (T. Rowe Price Health Sciences Portfolio) share a meaningful slice of their top holdings — about 79% by weight.

FHLC is cheaper at 0.084% vs 0.86% — a difference of $78 a year per $10,000 invested.

Over five years, FHLC returned +7.2% a year vs +4.1% for QAAGZX (reporting dates differ).

Updated Nov 19, 2026

FHLC vs QAAGZX side by side

FHLCQAAGZX
TypeETFETF
Fund familyFidelityT. Rowe Price
CategoryHealth Care SectorHealth Care Sector
Expense ratio0.084%0.86%
Annual cost per $10k$8.4$86
10-yr cost on $10k (prospectus)$108$1,061
Max front loadNoneNone
12b-1 fee0%0%
1-yr return+2.6%+18.1%
5-yr return (annualized)+7.2%+4.1%
10-yr return (annualized)+8.8%+9.0%
Best quarter+16.4%+23.4%
Worst quarter−13.1%−15.8%
Net assets (fund)$3.3B$751.7M
Number of holdings337277
Portfolio turnover3%65%
Returns as ofNov 30, 2025Dec 31, 2025

Source: SEC Form N-PORT and fund prospectuses

Year-by-year returns

YearFHLCQAAGZXDifference
2024+2.6%+1.7%+0.9%
2023+2.5%+3.0%−0.5%
2022−5.5%−12.5%+7.0%
2021+20.4%+13.1%+7.3%
2020+18.1%+29.6%−11.5%
2019+21.9%+29.0%−7.0%
2018+5.5%+1.1%+4.4%
2017+23.3%+27.6%−4.3%
2016−3.3%−10.5%+7.2%

Source: Fund prospectus bar charts

Holdings overlap

17 of FHLC's top 25 holdings also appear in QAAGZX's top 25.

Shared top holdings
HoldingFHLCQAAGZX
Eli Lilly & Co13.35%14.06%
Johnson & Johnson8.93%6.64%
AbbVie Inc6.42%5.12%
UnitedHealth Group Inc5.44%5.88%
Merck & Co Inc4.66%4.00%
Thermo Fisher Scientific Inc3.09%2.53%
Amgen Inc3.00%1.80%
Abbott Laboratories2.66%1.91%
Gilead Sciences Inc2.34%2.79%
Bristol-Myers Squibb Co1.93%2.12%
CVS Health Corp1.92%0.93%
Intuitive Surgical Inc1.82%1.89%
Danaher Corp1.80%1.44%
Vertex Pharmaceuticals Inc1.76%2.26%
Stryker Corp1.62%1.78%

Source: SEC Form N-PORT

FHLC top 10

  1. Eli Lilly & Co — 13.35%
  2. Johnson & Johnson — 8.93%
  3. AbbVie Inc — 6.42%
  4. UnitedHealth Group Inc — 5.44%
  5. Merck & Co Inc — 4.66%
  6. Thermo Fisher Scientific Inc — 3.09%
  7. Amgen Inc — 3.00%
  8. Abbott Laboratories — 2.66%
  9. Gilead Sciences Inc — 2.34%
  10. Pfizer Inc — 2.06%

QAAGZX top 10

  1. Eli Lilly & Co — 14.06%
  2. Johnson & Johnson — 6.64%
  3. Unitedhealth Group Inc — 5.88%
  4. Abbvie Inc — 5.12%
  5. Merck & Co. Inc. — 4.00%
  6. Gilead Sciences Inc — 2.79%
  7. Thermo Fisher Scientific Inc — 2.53%
  8. Vertex Pharmaceuticals Inc — 2.26%
  9. Bristol-myers Squibb Co — 2.12%
  10. Abbott Laboratories — 1.91%

FAQ

What is the difference between FHLC and QAAGZX?
FHLC (Fidelity MSCI Health Care Index ETF) and QAAGZX (T. Rowe Price Health Sciences Portfolio) share a meaningful slice of their top holdings — about 79% by weight. FHLC is cheaper at 0.084% vs 0.86% — a difference of $78 a year per $10,000 invested.
Which is cheaper, FHLC or QAAGZX?
FHLC has the lower expense ratio (0.084%).
Should I own both FHLC and QAAGZX?
Owning both adds little diversification because their portfolios overlap heavily; most investors pick one.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.